Samsara Bio Capital, LLC Scholar Rock Holding Corp Transaction History
Samsara Bio Capital, LLC
- $264 Million
- Q3 2025
A detailed history of Samsara Bio Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 5,612,896 shares of SRRK stock, worth $212 Million. This represents 79.46% of its overall portfolio holdings.
Number of Shares
5,612,896
Previous 5,612,896
-0.0%
Holding current value
$212 Million
Previous $199 Million
5.48%
% of portfolio
79.46%
Previous 85.36%
Shares
5 transactions
Others Institutions Holding SRRK
# of Institutions
277Shares Held
101MCall Options Held
2.02MPut Options Held
2.24M-
Siren, L.L.C. New York, NY9.25MShares$350 Million13.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$260 Million0.03% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$214 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$186 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.55MShares$172 Million0.03% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.95B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...